NCT07744152
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07744152
Title A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With Advanced Cancer (Solid Tumours)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ESP | DEU | BEL

Facility Status City State Zip Country Details
UZ Leuven NOT_YET_RECRUITING Leuven 3000 Belgium Details
Shanghai East Hospital NOT_YET_RECRUITING Shanghai 200123 China Details
Technische Universität Dresden NOT_YET_RECRUITING Dresden 01307 Germany Details
Klinikum der Universität München AÖR NOT_YET_RECRUITING München 81377 Germany Details
Nederlands Kanker Instituut - Antoni van Leeuwenhoek Amsterdam (METC AVL) NOT_YET_RECRUITING Amsterdam 1066CX Netherlands Details
Hospital del Mar RECRUITING Barcelona 08003 Spain Details
Hospital Universitari Vall d'Hebron NOT_YET_RECRUITING Barcelona 08035 Spain Details
Hospital Universitario 12 de Octubre RECRUITING Madrid 28041 Spain Details
Clínica Universidad de Navarra RECRUITING Navarra 31008 Spain Details
Hospital Clinico Universitario de Valencia NOT_YET_RECRUITING Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field